IgM-Enriched Immunoglobulin Attenuates Systemic Endotoxin Activity in Early Severe Sepsis: A Before-After Cohort Study
Fig 1
Flow of patients before (Control; n = 14) and after (IVIg; n = 12) integrating the IgM-IVIg application into the unit’s SOP as a treatment for patients with severe sepsis.